Moving beyond the vasodilator model in heart failure with reduced ejection fraction - lessons from sildenafil
- PMID: 35717600
- DOI: 10.1002/ejhf.2582
Moving beyond the vasodilator model in heart failure with reduced ejection fraction - lessons from sildenafil
Comment on
-
Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial.Eur J Heart Fail. 2022 Jul;24(7):1239-1248. doi: 10.1002/ejhf.2527. Epub 2022 Jun 6. Eur J Heart Fail. 2022. PMID: 35596935 Free PMC article. Clinical Trial.
References
-
- Borlaug BA, Reddy YNV. The role of the pericardium in heart failure: implications for pathophysiology and treatment. JACC Heart Fail. 2019;7:574-85.
-
- Desai AS, Solomon SD, Shah AM, Claggett BL, Fang JC, Izzo J, et al.; EVALUATE-HF Investigators. Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial. JAMA. 2019;322:1077-84.
-
- Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation. 2007;115:59-66.
-
- Hirata K, Adji A, Vlachopoulos C, O'Rourke MF. Effect of sildenafil on cardiac performance in patients with heart failure. Am J Cardiol. 2005;96:1436-40.
-
- Guazzi M, Vicenzi M, Arena R. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study. Eur J Heart Fail. 2012;14:82-90.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
